Generic World Pharmacy

With 13+ years of experience in pharma exports, we specialize in Premium-quality medications, Competitive Pricing, and Tailored packaging solutions.

Our unique packaging and hassle-free refund policies make us the top choice for dropshippers worldwide. We provide customized shipping options for every destination and ensure 24/7 support for seamless updates.

Our extensive warehousing capabilities guarantee reliable stock availability and smooth bulk shipments.

Product Name: Luprodex Depot 11.25mg Injection

Brand Names: Lupron Depot, Leuprolin, Prostap

Composition: Leuprolide (11.25mg)

Manufacturer/Marketer: Bharat Serums & Vaccines Ltd

Packaging: 2.0 ml in 1 vial

Treatment: Prostate cancer, endometriosis, uterine fibroids

Product Description: Luprodex Depot 11.25mg Injection contains a higher dose of Leuprolide, a synthetic hormone used in the treatment of hormone-dependent conditions such as advanced prostate cancer, endometriosis, and fibroids. It works by suppressing certain hormones, slowing the growth of tumors and helping to manage symptoms related to hormonal imbalance

Product Name: Duplat Depot 11.25 mg Combipack Injection

Brand Name: Duplat Depot

Composition: Leuprorelin (11.25 mg)

Manufacturer/Marketer: Samarth Life Sciences Pvt Ltd

Packaging: Combipack containing prefilled syringe and mixing components

Treatment:

• Prostate cancer
• Endometriosis
• Uterine fibroids
• Central precocious puberty (CPP)

Product Description: Duplat Depot 11.25 mg Combipack Injection contains Leuprorelin, a gonadotropin-releasing hormone (GnRH) agonist. It is used to manage hormone-sensitive conditions such as advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty. It works by decreasing hormone levels, leading to the suppression of symptoms associated with these conditions. Administered as a long-acting injection, typically every 3 months, the medication should be given under medical supervision. Common side effects may include hot flashes, fatigue, injection site reactions, and hormonal changes.

Nelabin 250 mg Injection contains Nelarabine, a chemotherapy medication used in the treatment of certain types of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Nelarabine is a prodrug of arabinosylguanine, which is converted inside the body to an active form that inhibits DNA synthesis in cancer cells, leading to cell death.

Nelabin is available in a strength of 250 mg per vial and is typically packaged as a single-use vial for intravenous administration. The intravenous form allows for direct delivery of the medication into the bloodstream, ensuring rapid and effective action against cancer cells.

The active ingredient, Nelarabine, interferes with the growth and proliferation of cancer cells by incorporating into their DNA and halting the replication process. This mechanism of action helps to reduce the number of cancerous cells in the body, contributing to the treatment and management of T-ALL and T-LBL.

The dosage and administration schedule of Nelabin are determined by the healthcare provider based on the patient's medical condition, body surface area, and response to treatment. It is crucial to follow the prescribed regimen precisely to achieve optimal results and minimize potential side effects.

Common side effects of Nelabin may include fatigue, nausea, vomiting, diarrhea, and decreased appetite. More serious side effects can occur, such as neurotoxicity, which may present as numbness, tingling, or weakness in the extremities. Regular monitoring by the healthcare provider is essential to manage any adverse effects and adjust the treatment as necessary.

Nelabin is manufactured by MSN Laboratories, a well-known pharmaceutical company dedicated to producing high-quality medications for various medical conditions. Patients receiving Nelabin should have regular follow-ups with their healthcare provider to monitor their response to the treatment and manage any side effects.

Nelabin 250 mg Injection offers an effective treatment option for patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Its targeted action against cancer cells helps to control the progression of these aggressive diseases, providing hope and improved outcomes for affected individuals. With its proven efficacy and reliable manufacturing, Nelabin is a trusted choice in oncology care.

Sigrima 420mg Injection

Brand Names: Sigrima, Perjeta (widely known brand based on composition)

Composition: Pertuzumab 420 mg

Strength: 420 mg/14 mL

Manufacturer: Glenmark Pharmaceuticals

Packaging: Typically available in a single-dose vial containing 14 mL of solution

Treatment: HER2-positive breast cancer

Product Description:
Sigrima 420mg Injection contains Pertuzumab, a monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2). Pertuzumab works by binding to the HER2 receptor, preventing it from pairing with other HER family receptors, which can lead to the growth of cancer cells. This action enhances the efficacy of other HER2-targeted therapies, such as trastuzumab, in treating HER2-positive breast cancer.

Common indications for Sigrima 420mg Injection include:

• HER2-Positive Breast Cancer: Used in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
• Neoadjuvant Treatment: Used in combination with trastuzumab and chemotherapy as neoadjuvant treatment for patients with HER2-positive, locally advanced, inflammatory, or early-stage breast cancer at high risk of recurrence.

Dosage and Administration:

• For Adults: The initial loading dose is typically 840 mg administered as an intravenous infusion over 60 minutes, followed by a maintenance dose of 420 mg every 3 weeks.
• Administration: Sigrima is administered as an intravenous infusion by a healthcare professional in a clinical setting. The dosage and frequency depend on the specific condition being treated and the patient’s response to therapy.

Common side effects of Sigrima 420mg Injection may include:

• Diarrhea
• Fatigue
• Nausea
• Alopecia
• Rash
• Neutropenia
• Peripheral neuropathy

Cardiac function should be monitored closely during treatment, as HER2-targeted therapies can affect heart function.

Packaging:
Sigrima 420mg Injection is typically packaged in a single-use vial containing 14 mL of solution, designed for single-dose use.

Sigrima 420mg Injection is a crucial component in the treatment of HER2-positive breast cancer, particularly when used in combination with other targeted therapies like trastuzumab. Its role in both metastatic and early-stage breast cancer provides significant benefits, helping to improve survival rates and reduce the risk of cancer recurrence. Close monitoring of the patient’s cardiac function and adherence to the prescribed infusion schedule are essential for optimizing treatment outcomes while managing potential side effects.

Inclisiran 284 mg Injection contains Inclisiran, a small interfering RNA (siRNA) medication used to lower cholesterol levels in the blood. It is specifically indicated for the treatment of hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH) and atherosclerotic cardiovascular disease (ASCVD) in adults who require additional lowering of LDL cholesterol.

Inclisiran is available in a strength of 284 mg per injection and is typically packaged as a single-use pre-filled syringe. This convenient packaging allows for easy administration, usually performed by a healthcare professional.

The active ingredient, Inclisiran, works by targeting and degrading the messenger RNA (mRNA) that encodes for the protein PCSK9 (proprotein convertase subtilisin/kexin type 9). By reducing the production of PCSK9, Inclisiran increases the number of LDL receptors on the surface of liver cells, enhancing the clearance of LDL cholesterol from the blood. This mechanism of action leads to a significant reduction in LDL cholesterol levels.

The usual dosage of Inclisiran involves an initial injection, followed by a second dose at 3 months, and subsequent doses every 6 months. This biannual dosing schedule offers a convenient and effective approach to managing cholesterol levels, especially for patients who may have difficulty adhering to daily medications.

Common side effects of Inclisiran may include injection site reactions, such as redness, pain, or swelling. These side effects are generally mild and temporary. However, any severe or persistent side effects should be reported to a healthcare provider promptly.

Inclisiran is manufactured by Novartis Pharmaceuticals, a leading global healthcare company known for its innovative treatments and commitment to improving patient outcomes. Regular monitoring of cholesterol levels and follow-ups with the healthcare provider are essential to assess the effectiveness of Inclisiran and make any necessary adjustments to the treatment plan.

Inclisiran 284 mg Injection provides a groundbreaking solution for managing high cholesterol levels, particularly in patients with ASCVD and familial hypercholesterolemia. Its novel siRNA mechanism offers a new approach to cholesterol reduction, helping to reduce the risk of cardiovascular events and improve overall cardiovascular health. With its convenient dosing schedule and proven efficacy, Inclisiran represents a significant advancement in lipid management therapy.

Aggramed Tirofiban Injection

Brand Names: Aggramed, Aggrastat (internationally known as)

Composition: Tirofiban

Strength: 0.25 mg/ml

Manufacturer: Emcure Pharmaceuticals Ltd.

Packaging: Single-use vial

Treatment: Acute Coronary Syndrome (ACS), Non-ST Elevation Myocardial Infarction (NSTEMI), Percutaneous Coronary Intervention (PCI)

Product Description:
Aggramed Tirofiban Injection contains Tirofiban, a glycoprotein IIb/IIIa inhibitor used in the management of acute coronary syndrome (ACS). It is indicated for use in patients experiencing non-ST elevation myocardial infarction (NSTEMI) or undergoing percutaneous coronary intervention (PCI). Tirofiban works by inhibiting platelet aggregation, which helps to prevent the formation of blood clots that can lead to heart attacks.

Aggramed is available in a concentration of 0.25 mg/ml and is typically packaged in single-use vials. This form allows for precise dosing and administration by healthcare professionals in a clinical setting.

Tirofiban, the active ingredient in Aggramed, blocks the glycoprotein IIb/IIIa receptors on the surface of platelets. These receptors are critical for platelet aggregation and thrombus formation. By inhibiting these receptors, Tirofiban reduces the risk of thrombotic events, thereby improving outcomes in patients with ACS.

The usual administration of Aggramed involves an initial bolus injection followed by a continuous intravenous infusion. The exact dosage and duration of treatment are determined by the healthcare provider based on the patient's clinical condition and response to therapy. It is crucial to follow the prescribed regimen to achieve the desired therapeutic effect.

Common side effects of Aggramed may include bleeding, which is the most significant risk due to its antiplatelet activity. Other side effects can include low platelet count (thrombocytopenia), headache, and dizziness. Patients receiving Aggramed should be closely monitored for signs of bleeding and other adverse effects.

Aggramed is manufactured by Emcure Pharmaceuticals Ltd., a reputable pharmaceutical company known for its commitment to quality and patient care. Regular follow-ups and monitoring by healthcare providers are essential to ensure the safety and effectiveness of the treatment.

Aggramed Tirofiban Injection offers an effective intervention for managing acute coronary syndrome and preventing thrombotic complications during percutaneous coronary interventions. Its targeted action on platelet aggregation makes it a vital tool in cardiology, helping to reduce the risk of adverse cardiovascular events and improve patient outcomes. With its reliable manufacturing and proven efficacy, Aggramed is a trusted choice in the management of ACS and related conditions.

• Prevention of Harmful effects of methotrexate

VINCRISTINE 1mg

Brand Names: Oncovin (widely known brand based on composition)

Composition: Vincristine Sulfate 1mg

Strength: 1mg per vial

Manufacturer: Various manufacturers (e.g., Pfizer, Emcure Pharmaceuticals)

Packaging: 1mg/1ml injection vial

Treatment: Cancer treatment (leukemia, lymphoma)

Product Description:
Vincristine 1mg is an injectable chemotherapy medication used primarily in the treatment of various cancers, including leukemia, lymphoma, and other malignancies. It works by inhibiting the growth of cancer cells by blocking cell division, making it a crucial drug in combination cancer therapies.

Indications for Vincristine include:

• Leukemia
• Hodgkin’s and non-Hodgkin’s lymphoma
• Wilms’ tumor
• Neuroblastoma

Dosage and Administration:

• Vincristine is administered via intravenous injection, usually once a week, and the dosage is determined based on the patient's body surface area and condition. Treatment duration varies depending on the type and stage of cancer being treated.

Common side effects of Vincristine may include:

• Numbness or tingling in hands and feet (peripheral neuropathy)
• Hair loss
• Constipation

Packaging:
Vincristine 1mg is typically available in 1mg/1ml sterile injection vials for single-use.

Vincristine is an essential part of many chemotherapy regimens due to its effectiveness in stopping cancer cell growth.

Product Name: Onco Bcg 40mg Injection

Brand Names: BCG-Vaccine, Tubervac, BCG-Onco

Composition: Bacillus Calmette-Guerin strain (40mg)

Manufacturer/Marketer: Cipla Ltd

Packaging: Vial for injection

Treatment: Bladder cancer

Product Description: Onco Bcg 40mg Injection contains Bacillus Calmette-Guerin (BCG) strain, a type of live bacteria used in immunotherapy. It is primarily used to treat superficial bladder cancer by stimulating the immune system to attack cancer cells in the bladder lining

Product Name: Leucorin 50mg Injection

Brand Name: Leucorin, Wellcovorin

Composition: Calcium Leucovorin (50mg)

Manufacturer/Marketer: Samarth Life Sciences Pvt Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Methotrexate toxicity, folic acid deficiency, colorectal cancer (as adjuvant therapy)

Product Description: Leucorin 50mg Injection contains Calcium Leucovorin, a folic acid derivative used to reduce the toxic effects of high-dose methotrexate therapy and treat folic acid deficiencies. It is also used as an adjuvant in the treatment of colorectal cancer to enhance the effectiveness of chemotherapy drugs like 5-fluorouracil

Relipoietin  Injection is a medicine that helps your bone marrow to produce more red blood cells. It is used to treat a type of anemia caused by kidney disease. It is also used to treat anemia caused by cancer chemotherapy and by taking medicines to treat HIV.

Relipoietin  Injection is given by injection either under the skin or into a vein which will be decided by your doctor. Usually, the injections are given by a nurse or doctor. The dose depends on your body weight and the cause of your anemia. Iron supplements both before and during treatment may make this treatment more effective. Relipoietin  Injection needs to be stored in a fridge but used at room temperature.

The most common side effects of taking this medicine include nausea, vomiting, fever, and increased blood pressure. It may also cause flu-like symptoms such as headache, tiredness, dizziness and aches and pains. These side effects are most common at the start of treatment but if they persist your doctor may be able to suggest ways of preventing or reducing them. Tell your doctor straight away if you get any serious side effects, including seizures (fits). Sometimes this medicine can cause serious blood clots that need urgent medical attention.

Before using Relipoietin  Injection you should tell your doctor if you have uncontrolled high blood pressure, heart disease, or gout (disease of joint pain). You should also tell him/her what other medicines you are taking in case they affect this treatment. Your blood pressure should be checked often during this treatment by you or your doctor. You may also need other regular medical tests to be sure this medicine is not causing harmful effects. It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.

USES OF RELIPOIETIN INJECTION

·         Treatment of Anemia due to chronic kidney disease

·         Treatment of Anemia due to cancer chemotherapy

BENEFITS OF RELIPOIETIN INJECTION

In Treatment of Anemia due to chronic kidney disease

Relipoietin  Injection is a man-made protein that helps your bone marrow to produce more red blood cells. It is used to treat anemia which is caused by kidney disease in adults and children who are on dialysis. Anemia is a condition where your body does not have enough red blood cells to carry oxygen around your body. This medicine helps reduce weakness and tiredness that you may be experiencing due to anemia. The injection is usually given by a doctor after a dialysis treatment.

In Treatment of Anemia due to cancer chemotherapy

Anemia is a condition where your body does not have enough red blood cells to carry oxygen around your body. Relipoietin  Injection is a man-made protein that works by stimulating the bone marrow (soft tissue inside the bones) to produce more red blood cells. The natural human form of this protein may be reduced when you are having chemotherapy to treat some types of cancer. An injection of the medicine can reduce the need to have a blood transfusion. You may also be given iron supplements to make the treatment more effective.

Oxaltero 100mg Injection is used in the treatment of cancer of colon and rectum. It shows its working by stopping or slowing down the growth of cancer cells.

Oxaltero 100mg Injection is given as an injection into vein by a qualified medical professional.  Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Nausea, fatigue, vomiting, and diarrhea are some common side effects of this medicine. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. It may cause some serious allergic reaction, inform your doctor if you notice sore lips or mouth ulcers, rash, itching and difficulty breathing. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. It makes men infertile, hence men should take doctor advice about the freezing of sperm before the treatment. You must avoid driving after taking this medicine as it may cause dizziness.

• In Cancer of colon and rectumCancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Oxaltero 100mg Injection treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.

• Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

• Nausea
• Fatigue
• Anemia (low number of red blood cells)
• Vomiting
• Diarrhea
• Decreased white blood cell count (neutrophils)
• Low blood platelets
• Increased liver enzymes
• Peripheral neuropathy (tingling and numbness of feet and hand)
• Stomatitis (Inflammation of the mouth)

• Your doctor or nurse will give you this medicine. Kindly do not self administer.

• Oxaltero 100mg Injection is an anti-cancer medication. It works by damaging the genetic material (DNA and RNA) of the cancer cells which stops their growth and multiplication.

Zoladex LA 10.8mg Injection is used for the treatment of prostate cancer in men.

Zoladex LA 10.8mg Injection is given as an injection under the skin by a qualified medical professional.  Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Hot flashes are a very common side effect of this medicine. It may also cause injection site reactions such as pain, swelling, and redness. The long-term use of medicine may cause weakened bones and a reduction in bone mineral density. You are advised to take vitamin D and calcium supplements while taking this medicine.

Before taking this medicine, inform your doctor if you have a history of drinking alcohol and diabetes. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.USES OF ZOLADEX INJECTION

• Prostate cancer

• Calutide 50mg (Genric Casodex) is an anti-androgen. It works in the body by preventing the actions of androgens (male hormones)
• Calutide 50mg (Genric Casodex) is used together with another hormone to treat prostate cancer

• 500mg CA Cape Tablets 
• we are Dealing In All Types Of Medicine 

PRODUCT INTRODUCTIONDurolane 20mg Injection is a medicine used in the treatment of osteoarthritis of the knee in patients who have failed to respond adequately to conservative therapy and simple analgesics. It reduces the swelling and stiffness in the joints and improve joint function.

Durolane 20mg Injection is generally administered by a doctor or a nurse. You should not self-administer this medicine at home. The dosage will depend on the the age, weight, and clinical condition of the patient as well as laboratory determinations. Get the injection for as long as the doctor has prescribed even if you get better until that doctor tells you it is alright to stop.

Common side effects of this medicine include injection site reactions (such as swelling, pain, and redness), joint swelling, and pain in the joints. If the side effects get worse or bother you, or if you experience any other symptoms which you think are caused by this medicine, let your doctor know. Your doctor may help with ways to reduce or prevent these symptoms.

To make sure the medicine is safe for you, let your doctor know of all the other medicines you are taking before using this medicine. If you are pregnant or breastfeeding, you should consult your doctor first before taking this medicine.

• Treatment of Osteoarthritis

• Joint swelling
• Joint pain
• Injection site inflammation

Cetuxa 100 mg Cetuximab Injection

Brand Names: Cetuxa, Erbitux (original brand name: Erbitux)

Composition: Cetuximab 100 mg

Strength: 100 mg per vial

Manufacturer: Various manufacturers, including Intas Pharmaceuticals Ltd.

Packaging: Typically available in single-use vials, containing 100 mg/20 ml solution.

Treatment: Colorectal cancer, head and neck cancer.

Product Description:
Cetuxa 100 mg Cetuximab Injection contains Cetuximab, a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) on the surface of cancer cells. By binding to EGFR, Cetuximab inhibits cell growth and promotes apoptosis (programmed cell death), making it effective in the treatment of certain types of cancers, particularly colorectal cancer and squamous cell carcinoma of the head and neck.

Common indications for Cetuxa 100 mg Injection include:

• Colorectal Cancer: For the treatment of EGFR-expressing, KRAS wild-type metastatic colorectal cancer in combination with chemotherapy or as a single agent.
• Head and Neck Cancer: For the treatment of locally advanced or metastatic squamous cell carcinoma of the head and neck in combination with radiation therapy or platinum-based chemotherapy.

Dosage and Administration:

• For Adults: The initial dose is typically 400 mg/m² body surface area as an intravenous infusion over 120 minutes. Subsequent weekly doses are 250 mg/m² over 60 minutes.
• Administration: Cetuxa is administered as an intravenous infusion. It should be prepared and administered by a healthcare professional in a clinical setting.

Common side effects of Cetuxa 100 mg Injection may include:

• Skin reactions (rash, itching)
• Hypomagnesemia (low magnesium levels)
• Infusion-related reactions (fever, chills, difficulty breathing)
• Nausea
• Diarrhea

Serious side effects can include severe infusion reactions, cardiopulmonary arrest, and interstitial lung disease. Immediate medical attention is required if any severe reactions occur during or after the infusion.

Packaging:
Cetuxa 100 mg Cetuximab Injection is typically packaged in single-use vials containing a 100 mg/20 ml solution, with clear instructions for dilution and administration.

Cetuxa 100 mg Cetuximab Injection is a targeted cancer therapy used in the treatment of specific types of cancer, providing an important option for patients with advanced colorectal and head and neck cancers.

Peggrafeel 6mg Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates bone marrow to produce white blood cells. These cells protect the body against infections.

Peggrafeel 6mg Injection is given as an injection by a qualified medical professional. You should continue to take as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. You might be asked for regular tests done to check the number of blood cells in your blood and your bone density level while you are taking this medicine.

The most common side effects of this medicine include bone pain, joint pain, headache, nausea, and muscle pain. Other than this, pain or redness at the site of injection is common. But, inform your doctor if you notice a lump, swelling, or bruising that does not go away. It might not prevent you from all kinds of infection, hence inform your doctor if you notice fever, chills, shortness of breath, sore throat, and swelling around the face or neck.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You must avoid driving or attention-seeking activity if you experience dizziness after taking this medicine.Uses of Peggrafeel Injection

• Prevention of Infections after chemotherapy

• Bone pain
• Joint pain
• Headache
• Nausea
• Low blood platelets
• Muscle pain
• Back pain
• Pain in extremities
• Injection site pain

Nuphos Cyclophosphamide 1000mg Injection

Brand Names: Nuphos, Cytoxan (original brand name: Cytoxan)

Composition: Cyclophosphamide

Strength: 1000 mg per vial

Manufacturer: Various manufacturers, including Celon Laboratories

Packaging: Single-use vial

Treatment: Various types of cancers, including lymphomas, leukemia, and breast cancer, as well as autoimmune disorders

Product Description:
Nuphos Cyclophosphamide 1000mg Injection contains Cyclophosphamide, an alkylating agent used in the treatment of various cancers and certain autoimmune disorders. Cyclophosphamide works by interfering with the growth of cancer cells, slowing or stopping their proliferation. It is a widely used chemotherapeutic agent due to its broad spectrum of activity against many types of tumors.

Common indications for Nuphos Cyclophosphamide Injection include:

• Cancers: Used in the treatment of lymphomas, leukemias, breast cancer, ovarian cancer, multiple myeloma, and other malignancies.
• Autoimmune Disorders: Sometimes used in lower doses to manage autoimmune diseases such as severe rheumatoid arthritis and lupus nephritis.

Dosage and Administration:
Nuphos Cyclophosphamide Injection is administered intravenously by a healthcare professional. The dosage depends on the type of cancer, the patient's size, and their response to treatment. The injection is typically given as part of a combination chemotherapy regimen. Hydration before and after administration is important to prevent bladder toxicity.

Common side effects of Nuphos Cyclophosphamide Injection may include:

• Nausea and vomiting
• Hair loss (alopecia)
• Loss of appetite
• Diarrhea
• Fatigue

More serious side effects can include bone marrow suppression leading to anemia, leukopenia (low white blood cell count), and thrombocytopenia (low platelet count), as well as bladder toxicity, hemorrhagic cystitis, and an increased risk of infections. Regular monitoring of blood counts and kidney function is essential during treatment.

Packaging:
Nuphos Cyclophosphamide 1000mg Injection is typically available in single-use vials, which must be reconstituted with a sterile diluent before intravenous administration.

Nuphos Cyclophosphamide 1000mg Injection is a critical component in the treatment of various cancers and certain autoimmune disorders. It requires careful handling and administration by healthcare professionals to ensure patient safety and therapeutic efficacy. Regular monitoring and supportive care are necessary to manage side effects and to maximize the treatment benefits.

Introduction to Darzalex 100mg Injection

Darzalex 100mg injection is a targeted therapy for cancer containing the active ingredient Daratumumab, which belongs to the group of medicine called monoclonal antibodies. Monoclonal antibodies are proteins that recognize and attach to the specific target, killing the cancer cells. It is used to treat a type of cancer called multiple myeloma (bone marrow cancer) in adults 18 years or older. Report to your doctor if you have ever had a hepatitis B infection; this medicine may cause the hepatitis B virus to become active again. This medicine can decrease platelets (helps in blood clotting) and white blood cell counts (helps fight infections). 

Do not take a Darzalex 100mg injection if you are allergic to Daratumumab or other medicine ingredients. This medicine is not recommended for children and adolescents. Inform your doctor if you get any infusion-related reactions, such as swollen face, lips, mouth, tongue, or throat. If you notice any infusion reactions, you need other medicine, or the infusion will be slowed down or stopped. 

Consult your doctor if you are on a salt-controlled diet, as this medicine contains sodium. Tell your physician if you have a history of breathing problems (asthma or chronic obstructive pulmonary disease) or had shingles before taking Darzalex 100mg. This medicine can change the results of blood tests to match your blood type. You must tell your healthcare provider you are being treated with this medicine before receiving blood transfusions. Inform your doctor if you are pregnant or planning to get pregnant. Use effective contraception during and after the treatment for three months.

• Treatment of Multiple myeloma

Therapeutic Effects of Darzalex 100mg Injection

Darzalex 100mg binds specifically to a protein called CD38 found on the surface of multiple myeloma cells. This binding can trigger the immune system to attack and kill the cancer cells.

Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional, supplements, and herbal products. In particular, tell your doctor if you are taking medicines for blood pressure or other heart conditions. Certain medications may interact with Darzalex 100mg and reduce its effectiveness by causing undesirable side effects. 

• Store Darzalex 100mg in the refrigerator (2°C to 8°C)
• Do not freeze
• keep the injection away from the reach of children and pets.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.

A trained doctor or nurse should only administer Darzalex 100mg. Do not self-administer the injection. Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors. It will be given as an intravenous infusion, and you will be monitored carefully for unwanted side effects. 

Product Name: Genticyn 80mg Injection

Brand Name: Genticyn, Garamycin, Amikacin

Composition: Gentamicin (80mg)

Manufacturer/Marketer: Abbott

Packaging: To be provided (specify packaging details if available)

Treatment: Bacterial infections, respiratory infections, urinary tract infections

Product Description: Genticyn 80mg Injection contains Gentamicin, an antibiotic used to treat serious bacterial infections. It works by inhibiting bacterial protein synthesis, effectively killing or stopping the growth of bacteria. It is commonly used for treating infections in the respiratory tract, urinary tract, and bloodstream, among others

Bleocel Bleomycin 15IU Injection

Brand Names: Bleocel, Blenoxane (widely known brand based on composition)

Composition: Bleomycin

Strength: 15 IU

Manufacturer: Celon Laboratories

Packaging: Typically available in a single-use vial

Treatment: Various types of cancer, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, and certain types of skin cancer

Product Description:
Bleocel Bleomycin 15IU Injection contains Bleomycin, an antineoplastic antibiotic that is used in the treatment of various types of cancer. Bleomycin works by causing breaks in DNA strands, leading to the inhibition of DNA synthesis in rapidly dividing cancer cells. It is commonly used as part of combination chemotherapy regimens for treating cancers such as Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, and certain types of skin cancer.

Common indications for Bleocel Bleomycin 15IU Injection include:

• Cancer Treatment: Used in the management of Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, and certain types of skin cancer.

Dosage and Administration:

• For Adults: The dosage and frequency of administration depend on the specific type of cancer being treated, the stage of the disease, and the patient's overall health. It is typically administered by a healthcare professional in a hospital or clinical setting.
• Administration: Bleocel is administered intravenously or intramuscularly under the supervision of an oncologist. The dosage schedule is determined based on the specific treatment protocol.

Common side effects of Bleocel Bleomycin 15IU Injection may include:

• Pulmonary toxicity (interstitial pneumonitis, pulmonary fibrosis)
• Skin reactions (hyperpigmentation, rash)
• Mucositis
• Fever and chills

Patients receiving Bleocel should be closely monitored for signs of pulmonary toxicity, which is a serious and potentially life-threatening side effect of Bleomycin.

Packaging:
Bleocel Bleomycin 15IU Injection is typically packaged in a single-use vial, intended for administration by a healthcare professional.

Bleocel Bleomycin 15IU Injection is a critical component of cancer therapy, particularly in the treatment of certain lymphomas, testicular cancer, and skin cancers. Due to its potential for serious side effects, it should only be administered under the guidance and supervision of an experienced oncologist. Regular monitoring of lung function and overall patient health is essential during treatment with Bleomycin.